;
Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/16 cls Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) Summer Street Jim Molloy New Buy 19% $280.26 Molloy initiated coverage with a $…

    Published on 5/19/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/9 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Cowen Nicholas Bishop Downgrade Market perform (from outperform) -25% $32.62 …

    Published on 5/12/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/2cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Bernstein Research Geoffrey Porges Upgrade Outperform (from market perform) 1% $155.…

    Published on 5/5/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/25 cls BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Brinson Patrick Christopher James New Market outperform -4% $8.01 James …

    Published on 4/28/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/17 cls Akebia Therapeutics Inc. (NASDAQ:AKBA) UBS Matthew Roden New Buy 55% $26.09 Roden initiated coverage with a $28 target on …

    Published on 4/21/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/11 cls Agios Pharmaceuticals Inc. (NASDAQ:AGIO) JPMorgan Geoffrey Meacham Upgrade Overweight (from neutral) 22% $43.32 Meacham also…

    Published on 4/14/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/4 cls GlycoMimetics Inc. (NASDAQ:GLYC) Jefferies Biren Amin Price target Buy 4% $15.77 Amin raised his target to $20 from $13 after…

    Published on 4/7/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/28 cls Endocyte Inc. (NASDAQ:ECYT) Leerink Partners Howard Liang Price target Market perform -22% $21.96 Wedbush Gregory Wade …

    Published on 3/31/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/21 cls Horizon Pharma Inc. (NASDAQ:HZNP) Cowen Edward Nash Price target Outperform 32% $17.35 Piper Jaffray Charles Duncan Price …

    Published on 3/24/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/14 cls Geron Corp. (NASDAQ:GERN) MLV Graig Suvannavejh Downgrade Hold (from buy) -60% $1.83 Piper Jaffray Charles Duncan …

    Published on 3/17/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 3/7 cls Biogen Idec Inc. (NASDAQ:BIIB) BMO Capital Markets Jim Birchenough Upgrade Outperform (from market perform) -4% $328.75 …

    Published on 3/10/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/28 cls Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) Maxim Group Echo He Upgrade Buy (from hold) -2% $8.69 Echo He upgraded and set an $…

    Published on 3/3/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/21 cls NPS Pharmaceuticals Inc. (NASDAQ:NPSP) Jefferies Eun Yang Downgrade Hold (from buy) 4% $38.57 Yang downgraded on valuation …

    Published on 2/24/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/14 cls Depomed Inc. (NASDAQ:DEPO) Roth Capital Partners Scott Henry Downgrade Neutral (from buy) 1% $12.30 Henry downgraded on the …

    Published on 2/17/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 2/7 cls Fluidigm Corp. (NASDAQ:FLDM) Cowen Doug Schenkel Downgrade Market perform (from outperform) -4% $43.11 Schenkel raised his …

    Published on 2/10/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/31 cls BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Wells Fargo Brian Abrahams Downgrade Market perform (from outperform) -12% $10.20…

    Published on 2/3/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/17 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Jefferies Eun Yang Upgrade Hold (from underperform) -3% $21.01 Ladenburg Thalmann …

    Published on 1/27/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/17 cls Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Leerink Partners Marko Kozul Price target Outperform 32% $87.36 Kozul raised his …

    Published on 1/20/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/10 cls Exelixis Inc. (NASDAQ:EXEL) Piper Jaffray Edward Tenthoff Upgrade Overweight (from neutral) 21% $7.44 Tenthoff also raised …

    Published on 1/13/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 1/3 cls Coronado Biosciences Inc. (NASDAQ:CNDO) Oppenheimer Boris Peaker Downgrade Market perform (from outperform) 1% $2.78 Peaker …

    Published on 1/6/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/20 cls Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) RBC Capital Markets Adnan Butt Downgrade Underperform (from sector performer) -1% $1…

    Published on 12/23/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/13 cls Ambit Biosciences Corp. (NASDAQ:AMBI) BMO Capital Markets Jim Birchenough Upgrade Outperform (from market perform) 20% $9.66…

    Published on 12/16/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/6 cls Biogen Idec Inc. (NASDAQ:BIIB) Bernstein Research Geoffrey Porges Price target Market perform 0% $290.90 Leerink Marko …

    Published on 12/9/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/22 cls Aerie Pharmaceuticals Inc. (NASDAQ:AERI) Canaccord Ritu Baral New Buy 9% $11.64 Baral initiated coverage with a $19 target,…

    Published on 11/25/2013
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/15 cls Cellular Dynamics International Inc. (NASDAQ:ICEL) Leerink Dan Leonard Downgrade Market perform (from outperform) -5% $14.79…

    Published on 11/18/2013

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993